GLP-1s significantly reduce appetite, slow digestion and promote weight loss.

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

Research that was just published in the medical journal JAMA Psychiatry shows 32 percent of patients with eating disorders ...

The BMA at its Annual Representative Meeting (ARM) in Brighton today passed a motion condemning the current state of eating ...

GLP-1 medications suppress appetite. What they cannot do is tell whether that appetite was disordered to begin with. For some ...

In contrast, prescription stimulants such as lisdexamfetamine, which have strong appetite suppressing effects and are sometimes prescribed for binge eating disorder (BED), were positively rated by ...

Eating disorders affect more than 5% of young people, and they have one of the highest mortality rates of any mental illness. Young patients with public health insurance have a much harder time ...

Sleep disturbances are a pervasive yet often under-recognised component of eating disorders. Patients with anorexia nervosa, bulimia nervosa and binge-eating disorder commonly report insomnia, ...

Sarah's (not her real name) relationship with food has been complicated since adolescence.While she used to "live to eat", ...